-13.4%
CTSH vs GSK
+24.3%
-37.8%
-54.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.8% | -2.7% | -1.1% | -3.2% |
| 7D | -5.5% | -4.2% | -1.3% | -4.5% |
| 30D | +4.5% | -7.5% | +12.0% | +6.4% |
| 3M | +13.7% | -3.3% | +17.0% | +14.9% |
| 6M | -8.4% | -9.3% | +0.9% | -6.4% |
| YTD | -26.5% | +1.6% | -28.1% | -27.7% |
| All | -13.4% | +24.3% | -37.8% | -17.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling